Private Management Group Inc. lowered its position in Chemours Company (The) (NYSE:CC) by 9.3% during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 846,092 shares of the specialty chemicals company’s stock after selling 87,126 shares during the period. Chemours Company (The) makes up approximately 1.8% of Private Management Group Inc.’s holdings, making the stock its 15th largest position. Private Management Group Inc. owned 0.46% of Chemours Company (The) worth $32,084,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also modified their holdings of CC. Swiss National Bank raised its position in shares of Chemours Company (The) by 1.9% in the second quarter. Swiss National Bank now owns 306,339 shares of the specialty chemicals company’s stock worth $11,616,000 after buying an additional 5,600 shares in the last quarter. Commerce Bank raised its position in shares of Chemours Company (The) by 3.0% in the second quarter. Commerce Bank now owns 7,158 shares of the specialty chemicals company’s stock worth $272,000 after buying an additional 206 shares in the last quarter. Principal Financial Group Inc. raised its position in shares of Chemours Company (The) by 5.3% in the second quarter. Principal Financial Group Inc. now owns 794,592 shares of the specialty chemicals company’s stock worth $30,131,000 after buying an additional 40,095 shares in the last quarter. 1060 Capital LLC acquired a new position in shares of Chemours Company (The) during the second quarter worth $9,525,000. Finally, Cambridge Investment Research Advisors Inc. raised its position in shares of Chemours Company (The) by 36.2% in the second quarter. Cambridge Investment Research Advisors Inc. now owns 10,296 shares of the specialty chemicals company’s stock worth $390,000 after buying an additional 2,738 shares in the last quarter. 72.87% of the stock is currently owned by institutional investors.

Shares of Chemours Company (NYSE:CC) traded up 0.3055% during mid-day trading on Friday, reaching $49.2199. The company had a trading volume of 151,235 shares. The company’s 50-day moving average is $46.80 and its 200 day moving average is $40.11. Chemours Company has a 52-week low of $12.47 and a 52-week high of $51.51. The stock has a market capitalization of $9.10 billion, a P/E ratio of 32.2120 and a beta of 3.63.

Chemours Company (The) (NYSE:CC) last released its quarterly earnings data on Wednesday, August 2nd. The specialty chemicals company reported $0.87 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.85 by $0.02. Chemours Company (The) had a net margin of 4.96% and a return on equity of 122.97%. The business had revenue of $1.59 billion during the quarter, compared to analyst estimates of $1.49 billion. During the same quarter in the previous year, the business earned $0.27 EPS. Chemours Company (The)’s quarterly revenue was up 14.8% compared to the same quarter last year. Analysts anticipate that Chemours Company will post $3.51 EPS for the current fiscal year.

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, September 15th. Investors of record on Thursday, August 17th will be paid a $0.03 dividend. This represents a $0.12 annualized dividend and a dividend yield of 0.24%. The ex-dividend date is Tuesday, August 15th. Chemours Company (The)’s payout ratio is presently 8.11%.

TRADEMARK VIOLATION NOTICE: This story was first posted by Watch List News and is the property of of Watch List News. If you are reading this story on another website, it was illegally stolen and republished in violation of U.S. and international copyright & trademark legislation. The original version of this story can be viewed at https://www.watchlistnews.com/chemours-company-the-cc-stake-lowered-by-private-management-group-inc/1536156.html.

A number of research analysts have weighed in on the company. BidaskClub raised Chemours Company (The) from a “hold” rating to a “buy” rating in a research note on Thursday, August 24th. Argus restated a “buy” rating and set a $55.00 price objective (up from $50.00) on shares of Chemours Company (The) in a report on Thursday, August 10th. UBS AG upgraded Chemours Company (The) from a “sell” rating to a “neutral” rating and upped their price objective for the stock from $36.00 to $50.00 in a report on Monday, August 7th. J P Morgan Chase & Co upped their price objective on Chemours Company (The) to $55.00 and gave the stock an “overweight” rating in a report on Friday, August 4th. Finally, Citigroup Inc. upped their price objective on Chemours Company (The) from $45.00 to $59.00 and gave the stock a “buy” rating in a report on Friday, August 4th. One analyst has rated the stock with a hold rating, eight have given a buy rating and one has issued a strong buy rating to the company’s stock. The company currently has an average rating of “Buy” and an average price target of $51.50.

In related news, VP Amy Trojanowski sold 2,500 shares of Chemours Company (The) stock in a transaction on Friday, August 11th. The shares were sold at an average price of $46.03, for a total value of $115,075.00. The sale was disclosed in a filing with the SEC, which is available at the SEC website. Also, insider Paul Kirsch sold 19,036 shares of Chemours Company (The) stock in a transaction on Monday, June 5th. The stock was sold at an average price of $41.42, for a total transaction of $788,471.12. The disclosure for this sale can be found here. In the last ninety days, insiders sold 31,536 shares of company stock valued at $1,365,946. 1.14% of the stock is owned by company insiders.

Chemours Company (The) Company Profile

The Chemours Company is a provider of performance chemicals. The Company operates through three segments: Titanium Technologies, Fluoroproducts and Chemical Solutions. The Titanium Technologies segment is a producer of titanium dioxide (TiO2). The Fluoroproducts segment is a provider of fluoroproducts, including refrigerants and industrial fluoropolymer resins.

Want to see what other hedge funds are holding CC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Chemours Company (The) (NYSE:CC).

Institutional Ownership by Quarter for Chemours Company (The) (NYSE:CC)

Receive News & Ratings for Chemours Company (The) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Chemours Company (The) and related companies with Analyst Ratings Network's FREE daily email newsletter.